Research progress of vaccine therapy in non-small cell lung cancer
10.3969/j.issn.1000-8179.20150676
- VernacularTitle:非小细胞肺癌疫苗的研究进展
- Author:
Yuequan SHI
;
Minjie WEI
- Publication Type:Journal Article
- Keywords:
lung neoplasm;
vaccine;
clinical trial
- From:
Chinese Journal of Clinical Oncology
2015;(15):778-782
- CountryChina
- Language:Chinese
-
Abstract:
Immunotherapy, particularly lung cancer vaccine therapy, has advantages of less side effects and low costs over classi-cal therapies of lung cancer, such as surgery, radiotherapy, and chemotherapy, as well as the relatively new molecular targeting therapy. PhaseⅢclinical trial for many kinds of non-small cell lung cancer (NSCLC) vaccines is ongoing based on deeper understanding of im-mune system and the expression of tumor antigens. This review summarizes the development of NSCLC vaccines.
